ZNTL

NKIO

This company develops natural killer cell therapies and small molecule medicines to treat solid tumours for patients with cancer and inflammatory diseases.

Kinnate Biopharma

The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.

RYZB

This company develops targeted radiopharmaceutical therapeutics for patients with solid tumours.

LYEL

This company develops engineered cell therapies to treat patients with solid tumours and blood cancers.

TPTX

This biopharmaceutical company develops small molecule tyrosine kinase inhibitors to treat patients with advanced solid tumours and lung cancer.

Nuvalent

This biopharmaceutical company develops targeted small molecule kinase inhibitors for patients with genomically defined cancers such as non-small cell lung cancer.

IMGO

This biopharmaceutical company develops small molecule therapies targeting epigenetic enzymes to treat patients with bone marrow diseases and chronic blood cancers.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.